Check out our most popular compounded medications! Get Started
The Lansoprazole 3 mg/ml Gastric Tube Liquid is a specially compounded medication intended for administration through a gastric tube. This formulation is designed to provide accurate dosing and safe delivery of lansoprazole, a proton pump inhibitor, for patients who are unable to swallow oral medications. It is primarily used in hospital settings or for home care patients with swallowing difficulties.
Lansoprazole works by reducing the amount of acid produced in the stomach. This gastric tube liquid formulation is indicated for the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome. It may also be used for the prevention of gastric ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs) or for the treatment of Helicobacter pylori infection as part of a combination therapy.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Lansoprazole 3 mg/ml Gastric Tube Liquid is a specially compounded medication designed for ease of administration through a gastric tube, providing an essential solution for patients who are unable to swallow oral medications. This formulation is particularly beneficial in hospital settings or for home care patients with dysphagia or other conditions that impair their ability to take medications orally. The liquid form ensures that the active ingredient, lansoprazole, is delivered in a precise, controlled manner, which is critical for maintaining the appropriate therapeutic levels of the medication.
Lansoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). It works by reducing the amount of acid produced in the stomach, thereby offering relief from symptoms and promoting healing in various acid-related gastrointestinal conditions. This medication is commonly prescribed for the treatment of gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. By decreasing stomach acid, lansoprazole can help prevent the esophageal damage that can occur from acid reflux, allow ulcers to heal, and manage the overproduction of acid associated with Zollinger-Ellison syndrome.
For patients and prescribers considering the use of Lansoprazole 3 mg/ml Gastric Tube Liquid, it is important to understand that the compounding process ensures the stability and compatibility of lansoprazole in liquid form, which is not commercially available. The pharmacists at Bayview Pharmacy take great care in preparing this formulation to meet the specific needs of individual patients, adhering to strict compounding guidelines to ensure safety and efficacy. The concentration of 3 mg/ml allows for flexible dosing, tailored to the patient's requirements, and the liquid form facilitates accurate dosing adjustments.
It is essential for prescribers to provide detailed instructions regarding the administration of this medication, including the appropriate dosing schedule and any necessary precautions to ensure the medication's effectiveness and minimize potential side effects. Patients or caregivers should be educated on the proper technique for administering the medication through a gastric tube to avoid complications such as tube blockages or improper delivery of the drug.
If you have any questions or require further information about Lansoprazole 3 mg/ml Gastric Tube Liquid, or if you need guidance on its use for specific disease states, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of expert compounding pharmacists is committed to providing support and advice to ensure the best possible outcomes for our patients.
Lansoprazole is a proton pump inhibitor (PPI) that works by reducing the amount of acid produced in the stomach. It is used to treat conditions such as gastroesophageal reflux disease (GERD), ulcers, and other conditions where a reduction in gastric acid secretion is beneficial. When administered as a 3 mg/ml gastric tube liquid, it is particularly useful for patients who are unable to swallow oral medications, ensuring they receive the necessary treatment.
However, lansoprazole can interact with a variety of medications, potentially altering their effects. It is important to consider these interactions when prescribing or administering lansoprazole. For example, lansoprazole may increase the blood levels of certain drugs, such as theophylline, warfarin, and tacrolimus, by decreasing their breakdown in the liver. This could lead to an increased risk of side effects from these medications. Close monitoring and possible dose adjustments may be necessary when these drugs are used concurrently with lansoprazole.
Conversely, lansoprazole can decrease the absorption of drugs that require an acidic environment for proper absorption. This includes medications such as ketoconazole, itraconazole, iron salts, and certain forms of antiretroviral drugs. Patients may need to take these medications at a different time than lansoprazole to ensure adequate absorption.
Lansoprazole may also interact with clopidogrel, an antiplatelet medication. It can reduce the effectiveness of clopidogrel by inhibiting the enzyme that converts clopidogrel to its active form. This could potentially increase the risk of cardiovascular events in patients taking both medications. Alternative treatments or careful monitoring may be advised in such cases.
Additionally, chronic use of lansoprazole, as with other PPIs, can lead to decreased absorption of vitamin B12 and magnesium, which could result in deficiencies if not monitored and supplemented as necessary. Long-term use also carries a risk of increased bone fracture, particularly in the elderly or in those with other risk factors for osteoporosis.
It is crucial to review all medications, including over-the-counter drugs and supplements, that a patient is taking before starting lansoprazole to avoid potential interactions. Adjustments to medication regimens or monitoring may be required to manage these interactions effectively. If you have any questions or concerns regarding the use of lansoprazole 3 mg/ml gastric tube liquid and potential drug interactions, please reach out to us at Bayview Pharmacy for further assistance.
Lansoprazole is a proton pump inhibitor (PPI) that works by blocking the enzyme in the wall of the stomach that produces acid. By inhibiting this enzyme, known as H+/K+-ATPase, lansoprazole effectively reduces the production of stomach acid. This decrease in stomach acid allows for the healing of acid-related damage to the lining of the esophagus and stomach, and it helps in the management of conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. The reduction of acid also aids in preventing the formation of new ulcers and facilitates the effectiveness of antibiotics in the treatment of ulcers caused by the bacteria Helicobacter pylori.
The Lansoprazole 3 mg/ml Gastric Tube Liquid formulation is specifically designed for patients who are unable to swallow oral medications, which includes individuals with dysphagia, those who are unconscious or on mechanical ventilation, and patients with esophageal abnormalities. The liquid form ensures that the medication can be accurately measured and administered through a gastric tube directly into the stomach, bypassing the need for swallowing. This is particularly important for ensuring that the correct dose is delivered to the site of action without being compromised by the patient's inability to swallow pills or capsules.
When using this formulation, it is crucial to follow proper administration techniques to maintain the stability and effectiveness of the medication. The liquid should be administered slowly through the gastric tube to ensure proper delivery to the stomach and to prevent clogging of the tube. Additionally, the gastric tube should be flushed with a suitable fluid before and after the administration of the medication to ensure the entire dose is delivered and to maintain tube patency.
For prescribers, it is important to note that the efficacy of lansoprazole as a PPI is dependent on its absorption and conversion to the active form within the acidic environment of the parietal cells in the stomach. Therefore, the timing of the dose in relation to meals may affect the drug's effectiveness, as food intake can alter the stomach's acidity. Prescribers should also be aware of potential drug interactions, as lansoprazole may affect the absorption of other medications that depend on stomach pH for optimal absorption.
Patients and prescribers should monitor for common side effects, which may include headache, diarrhea, nausea, abdominal pain, or constipation. Long-term use of PPIs, such as lansoprazole, should be managed carefully, as it may be associated with an increased risk of bone fractures, vitamin B12 deficiency, and magnesium deficiency, among other potential risks.
If you have any questions or require further information about the Lansoprazole 3 mg/ml Gastric Tube Liquid formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing support and guidance to ensure the safe and appropriate use of this medication.
Lansoprazole 3 mg/ml Gastric Tube Liquid is a medication used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). It works by decreasing the amount of acid your stomach makes. The liquid formulation is designed for patients who are unable to take oral medications and is administered via a gastric tube.
Lansoprazole Gastric Tube Liquid is administered through a gastric tube using a syringe to inject the medication directly into the stomach. This ensures that the medication is delivered effectively in patients who have difficulty swallowing or cannot take medications orally.
It is important to consult with a healthcare provider before combining Lansoprazole with other medications. Some drugs may interfere with Lansoprazole, affecting its effectiveness or increasing the risk of side effects.
The dosage of Lansoprazole 3 mg/ml Gastric Tube Liquid depends on the patient's medical condition and response to treatment. It is crucial to follow the prescribed dose by a healthcare provider to ensure optimal treatment and safety.
If a dose is missed, administer it as soon as you remember. However, if it is near the time of the next dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to catch up.
As with any medication, Lansoprazole may cause side effects. Common side effects can include nausea, stomach pain, diarrhea, and headache. If side effects are severe or persistent, it is important to contact a healthcare professional.
Lansoprazole Gastric Tube Liquid should be stored at room temperature, away from light and moisture, and out of reach of children and pets. Do not store in the bathroom or freeze the medication.
Lansoprazole should not be mixed with food or other liquids unless instructed by a healthcare professional. Mixing it may affect the way the medication works or may cause blockage in the gastric tube.
It is important to discuss any medical history, especially liver disease and other stomach issues (like tumors), with a healthcare provider. Additionally, inform the provider about any allergies to Lansoprazole or similar drugs as well as all other medications, supplements, and herbal products you are taking.
Lansoprazole Gastric Tube Liquid begins to work within several hours of administration. However, it may take one to four days to feel the full benefit of the medication. Patients should continue to take the medication as directed, even if they feel better, as premature discontinuation may result in a return of symptoms.
Lansoprazole Gastric Tube Liquid may be used in children if prescribed by a healthcare provider. The dosage will be adjusted based on the child's weight and medical condition. Always consult a pediatrician or gastroenterologist experienced in treating pediatric patients before administration.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
